The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity

被引:6
|
作者
de Mare, Arjan [1 ]
Bungener, Laura B. [1 ]
Regts, Joke [1 ]
de Vries-Idema, Jacqueline [1 ]
van der Zee, Ate G. J. [2 ]
Witschut, Jan [1 ]
Daemen, Toos [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Mol Virol Sect, Dept Med Microbiol, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Dept Gynecol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands
关键词
virosome; CTL; pre-existing immunity;
D O I
10.1016/j.vaccine.2008.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Protein antigens encapsulated in virosomes generated from influenza virus can induce antigen-specific cytotoxic T lymphocyte (CTL) responses. In the present study we determined, in a murine model system, whether pre-existing immunity against influenza virus hampers the induction of a CTL response. CTL induction was only slightly reduced by pre-injection of influenza virus-specific antibodies or pre-exposure to influenza virus. Both pre-treatments resulted in the same level of reduction, suggesting that virus-specific antibodies rather than T cell responses account for the reduction. Furthermore, a booster immunization enhanced CTL activation, indicating that virosome-specific immunity induced by a prime immunization does not hamper the booster effect. In conclusion, CTL induction against virosome-encapsulated protein antigens is not significantly inhibited by pre-existing humoral or cellular immunity against influenza virus. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2314 / 2321
页数:8
相关论文
共 50 条
  • [21] EFFECT OF RIMANTADINE ON CYTOTOXIC LYMPHOCYTE-T RESPONSES AND IMMUNITY TO REINFECTION IN MICE INFECTED WITH INFLUENZA-A VIRUS
    HERRMANN, JE
    WEST, K
    BRUNS, M
    ENNIS, FA
    JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (02): : 180 - 184
  • [22] Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses
    Carlock, Michael A.
    Ingram, John G.
    Clutter, Emily F.
    Cecil, Noah C.
    Ramgopal, Moti
    Zimmerman, Richard K.
    Warren, William
    Kleanthous, Harry
    Ross, Ted M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (09) : 2030 - 2043
  • [23] Pre-Existing Immunity with High Neutralizing Activity to 2009 Pandemic H1N1 Influenza Virus in Shanghai Population
    Liu, Xiaoqing
    Liu, Yuan
    Zhang, Yanjun
    Chen, Zhihui
    Tang, Ziwei
    Xu, Qingqiang
    Wang, Yue
    Zhao, Ping
    Qi, Zhongtian
    PLOS ONE, 2013, 8 (03):
  • [24] Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity
    Doling, AM
    Ballard, JD
    Shen, H
    Krishna, KM
    Ahmed, R
    Collier, RJ
    Starnbach, MN
    INFECTION AND IMMUNITY, 1999, 67 (07) : 3290 - 3296
  • [25] Effect of pre-existing anti-LT (heat-labile enterotoxin of Escherichia coli) immunity on the efficacy of oral influenza vaccine
    Lu, XH
    Katz, JM
    FASEB JOURNAL, 2002, 16 (04): : A680 - A680
  • [27] CYTOTOXIC T-LYMPHOCYTE MEMORY - ROLE IN CROSS-PROTECTIVE IMMUNITY AGAINST INFLUENZA
    RIMMELZWAAN, GF
    OSTERHAUS, ADME
    VACCINE, 1995, 13 (08) : 703 - 705
  • [28] Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific cytotoxic T-lymphocyte precursors in the periphery
    Tanaka, S
    Harada, M
    Mine, T
    Noguchi, M
    Gohara, R
    Azuma, K
    Tamura, M
    Yamada, A
    Morinaga, A
    Nishikori, M
    Katagiri, K
    Itoh, K
    Yamana, H
    Hashimoto, T
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (04): : 357 - 366
  • [29] Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia a mice with pre-existing factor VIII immunity
    Doering, Christopher B.
    Gangadharan, Bagirath
    Dukart, Hillary Z.
    Spencer, H. Trent
    MOLECULAR THERAPY, 2007, 15 (06) : 1093 - 1099
  • [30] EFFECTIVENESS OF CHOLERA TOXIN-B SUBUNIT AS AN ADJUVANT FOR NASAL INFLUENZA VACCINATION DESPITE PRE-EXISTING IMMUNITY TO CTB
    TAMURA, S
    FUNATO, H
    NAGAMINE, T
    AIZAWA, C
    KURATA, T
    VACCINE, 1989, 7 (06) : 503 - 505